Table 2.
Clinical course of SARS-CoV-2 infection in patients suffering from chronic kidney disease
| Study cohort: Chronic kidney disease | |
|---|---|
| Symptoms at first positive SARS-CoV-2 detection—no. (%) | |
| Symptomatic | 293 (86.4) |
| Dyspnea | 86 (25.5) |
| Other respiratory symptomsa | 107 (32.6) |
| Gastrointestinal symptomsb | 44 (12.7) |
| Weaknessc | 64 (18.7) |
| Smell or taste disorder | 6 (1.8) |
| Phased at first positive SARS-CoV-2 detection—no. (%) | |
| Uncomplicated phase | 229 (54.1) |
| Complicated phase | 163 (38.5) |
| Critical phase | 19 (4.5) |
| Recovery phase | 0 (0.0) |
| Dead | 12 (2.8) |
| Phasesd in the course of disease—no. (%) | |
| Uncomplicated phase | 333 (78.2) |
| Complicated phase | 273 (64.1) |
| Critical phase | 118 (27.7) |
| Hospitalizatione in the course of disease—no. (%) | |
| Inpatient treatment | 304 (97.1) |
| ICU treatment | 112 (37.3) |
| Length of inpatient treatmente—median (IQR) days | |
| Duration of overall inpatient stay | 13 (7–21) |
| Duration of ICU stay | 11 (5–19) |
| Outcomes—no. (%) | |
| Invasive ventilation | 67 (16.2) |
| Death | 140 (32.9) |
Continuous variables are expressed as median and interquartile range (IQR), categorical variables as numbers (no.) and percentages (%) referred to the numbers excluding missing data. Missing rates and frequency distribution are displayed in Suppl. Table 2 for variables with missing rate > 5%
ICU intensive care unit
aOther respiratory symptoms include runny nose, sore throat, dry or productive cough
bGastrointestinal symptoms include diarrhea, nausea or emesis
cWeakness includes muscle weakness or excessive tiredness
dPhases according to the LEOSS definition as shown in Fig. 1
ePatients receiving inpatient and/or ICU treatment for more than 4 days before the detection of SARS-CoV-2 were not considered